MF
ACAD icon

Manchester Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Manchester Financial’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-583
Closed -$15K – 86
2021
Q1 		$15K Buy
583
+108
+23% +$4.75K 0.01% 358
2020
Q4 		$25K Hold
475
– – 0.02% 244
2020
Q3 		$20K Hold
475
– – 0.02% 236
2020
Q2 		$23K Hold
475
– – 0.02% 214
2020
Q1 		$20K Hold
475
– – 0.01% 206
2019
Q4 		$20K Buy
+475
New +$20.7K 0.01% 262
2019
Q3 		– Sell
-475
Closed -$13K – 65
2019
Q2 		$13K Buy
+475
New +$12.1K 0.01% 296

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return